Skip to main content
Caplight Logo









NOVOS

NOVOS

Private
New York City, New YorkHealthcare & Life Scienceshttps://novoslabs.com/

Last Round

Strategic

Mar 5, 2026

Total Funding Raised

$3.15M

Company Overview

NOVOS is a longevity biotechnology company that develops science-backed nutraceuticals and personalized tools to support healthy aging and extend human healthspan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

longevity supplementsbiohackingbiological age testNAD+ precursorhealthspanDTC supplementspreventative healthanti-agingsubscription commercewellness appAI longevity coachhealth optimizationnutritional interventionbiological clock

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NOVOS Comparables

Compare NOVOS with similar companies based on industry and business-model similarity.

NOVOS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elysium Health
91%
DoNotAge
88%
Blueprint
87%

NOVOS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 5, 2026
Pre SeedOct 1, 2021

Key People

Founding team and executive leadership

Chris Mirabile

Founder, CEO

Founding Team

NOVOS Investors

Notable investors and investment history

NOVOS investors
InvestorRounds
Awesome People VenturesPre Seed
Uncommon DenominatorPre Seed
Longevitytech.fundPre Seed
Resolute VenturesPre Seed
Arkitekt VenturesPre Seed
Arkitekt VenturesPre Seed
Unilever VenturesStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 19, 2025

    Added The Big Fat Fix, a media startup, as a customer.

NOVOS Filings

Explore SEC and related filing metadata, where available.

NOVOS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NOVOS's valuation, stock price, and market status.

Is NOVOS a public or private company?

NOVOS is a private company.

What is the current stock price of NOVOS?

NOVOS is a private company with no public stock price. No recent secondary market data is available.

How much is NOVOS worth (valuation)?

Valuation information for NOVOS is not publicly available.

Can I buy NOVOS stock?

NOVOS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NOVOS's last funding round?

NOVOS's most recent funding round was Pre Seed on October 1, 2021.

Who are the main investors in NOVOS?

Key investors in NOVOS include Resolute Ventures.

Will NOVOS IPO soon?

No public IPO plans have been announced for NOVOS.

How can I track NOVOS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NOVOS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range16
Year Founded2018
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?